Health and economic impact of rotavirus vaccination in GAVI-eligible countries
Open Access
- 14 May 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 10 (1), 253
- https://doi.org/10.1186/1471-2458-10-253
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Exploring Model Uncertainty in Economic Evaluation of Health Interventions: The Example of Rotavirus Vaccination in VietnamMedical Decision Making, 2010
- Rotavirus Disease Burden and Impact and Cost‐Effectiveness of a Rotavirus Vaccination Program in KenyaThe Journal of Infectious Diseases, 2009
- Demographic Variability, Vaccination, and the Spatiotemporal Dynamics of Rotavirus EpidemicsScience, 2009
- Cost-effectiveness of Rotavirus vaccination in VietnamBMC Public Health, 2009
- Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of MexicoBMC Infectious Diseases, 2008
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008
- Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III studyThe Lancet, 2008
- Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical reviewEpidemiology and Infection, 2007
- Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United KingdomEpidemiology and Infection, 2007
- Heterogeneity and Temporal Dynamics of Evolution of G1 Human Rotaviruses in a Settled PopulationJournal of Virology, 2006